• Something wrong with this record ?

Selective binding of tumor suppressor p53 protein to topologically constrained DNA: modulation by intercalative drugs

H. Pivoňková, P. Šebest, P. Pecinka, O. Tichá, K. Nemcová, M. Brázdová, EB. Jagelská, V. Brázda, M. Fojta

. 2010 ; 393 (4) : 894-899. [pub] 20100220

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Selective binding of the wild type tumor suppressor protein p53 to negatively and positively supercoiled (sc) DNA was studied using intercalative drugs chloroquine (CQ), ethidium bromide, acridine derivatives and doxorubicin as a modulators of the level of DNA supercoiling. The p53 was found to lose gradually its preferential binding to negatively scDNA with increasing concentrations of intercalators until the DNA negative superhelix turns were relaxed. Formation of positive superhelices (due to further increasing intercalator concentrations) rendered the circular duplex DNA to be preferentially bound by the p53 again. CQ at concentrations modulating the closed circular DNA topology did not prevent the p53 from recognizing a specific target sequence within topologically unconstrained linear DNA. Experiments with DNA topoisomer distributions differing in their superhelix densities revealed the p53 to bind selectively DNA molecules possessing higher number of negative or positive superturns. Possible modes of the p53 binding to the negatively or positively supercoiled DNA and tentative biological consequences are discussed.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12025165
003      
CZ-PrNML
005      
20170626103954.0
007      
ta
008      
120816s2010 xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.bbrc.2010.02.120 $2 doi
035    __
$a (PubMed)20175992
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Pivoňková, Hana $7 xx0104637 $u Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Královopolská 135, 612 65 Brno, Czech Republic. hapi@ibp.cz
245    10
$a Selective binding of tumor suppressor p53 protein to topologically constrained DNA: modulation by intercalative drugs / $c H. Pivoňková, P. Šebest, P. Pecinka, O. Tichá, K. Nemcová, M. Brázdová, EB. Jagelská, V. Brázda, M. Fojta
520    9_
$a Selective binding of the wild type tumor suppressor protein p53 to negatively and positively supercoiled (sc) DNA was studied using intercalative drugs chloroquine (CQ), ethidium bromide, acridine derivatives and doxorubicin as a modulators of the level of DNA supercoiling. The p53 was found to lose gradually its preferential binding to negatively scDNA with increasing concentrations of intercalators until the DNA negative superhelix turns were relaxed. Formation of positive superhelices (due to further increasing intercalator concentrations) rendered the circular duplex DNA to be preferentially bound by the p53 again. CQ at concentrations modulating the closed circular DNA topology did not prevent the p53 from recognizing a specific target sequence within topologically unconstrained linear DNA. Experiments with DNA topoisomer distributions differing in their superhelix densities revealed the p53 to bind selectively DNA molecules possessing higher number of negative or positive superturns. Possible modes of the p53 binding to the negatively or positively supercoiled DNA and tentative biological consequences are discussed.
650    _2
$a akridiny $x chemie $x farmakologie $7 D000166
650    _2
$a kompetitivní vazba $7 D001667
650    _2
$a chlorochin $x chemie $x farmakologie $7 D002738
650    _2
$a superhelikální DNA $x chemie $x účinky léků $x metabolismus $7 D004278
650    _2
$a doxorubicin $x chemie $x farmakologie $7 D004317
650    _2
$a lidé $7 D006801
650    _2
$a interkalátory $x chemie $x farmakologie $7 D007364
650    _2
$a konformace nukleové kyseliny $x účinky léků $7 D009690
650    _2
$a nádorový supresorový protein p53 $x chemie $x metabolismus $7 D016159
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Šebest, Peter $7 xx0214723
700    1_
$a Pečinka, Petr, $d 1964- $7 mzk2008442837
700    1#
$a Tichá, Olga. $7 xx0199420
700    1_
$a Němcová, Kateřina $7 xx0100595
700    1_
$a Brázdová, Marie $7 xx0100610
700    1_
$a Brázdová Jagelská, Eva $7 xx0098364
700    1_
$a Brázda, Václav, $d 1970- $7 nlk20010096077
700    1_
$a Fojta, Miroslav, $d 1967- $7 xx0060599
773    0_
$w MED00009307 $t Biochemical and biophysical research communications $x 1090-2104 $g Roč. 393, č. 4 (2010), s. 894-899
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20175992 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20170626104416 $b ABA008
999    __
$a ok $b bmc $g 947207 $s 782511
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 393 $c 4 $d 894-899 $e 20100220 $i 1090-2104 $m Biochemical and biophysical research communications $n Biochem Biophys Res Commun $x MED00009307
LZP    __
$a Pubmed-20120816/10/02

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...